Insys Agrees to $225 Million, 5-Year Settlement of U.S. Opioid Sales Claims June 6, 2019 By Jef Feeley, Riley Griffin Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay...
